Cormedix Inc. Reports Fourth Quarter And Full Year 2024 Financial Results And Provides Business Update
Net Revenue of $31.2mm; 2024 Net Revenue of ‒ ‒ Q4 Net Income of and Adjusted EBITDA of ‒ ‒ Conference Call Scheduled for ...
BNP Paribas: Still Valuable But Headwinds Have Emerged (Rating Downgrade)
BNP Paribas SA showcases strong growth and solid fundamentals. See why BNPQF stock is deemed a 'Buy' amidst economic risks ...